Bicocca Open Archive

Logo unimib boa
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.904
AS - Asia 9.743
EU - Europa 7.343
SA - Sud America 1.591
AF - Africa 171
OC - Oceania 52
Continente sconosciuto - Info sul continente non disponibili 8
Totale 33.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.593
SG - Singapore 3.518
CN - Cina 2.144
HK - Hong Kong 1.936
RU - Federazione Russa 1.651
IT - Italia 1.597
BR - Brasile 1.243
VN - Vietnam 1.056
IE - Irlanda 872
DE - Germania 756
SE - Svezia 733
GB - Regno Unito 462
ID - Indonesia 265
UA - Ucraina 228
CA - Canada 176
FR - Francia 163
IN - India 159
AR - Argentina 148
ES - Italia 135
NL - Olanda 135
KR - Corea 129
AT - Austria 124
JP - Giappone 124
FI - Finlandia 100
MX - Messico 88
PL - Polonia 78
BD - Bangladesh 76
ZA - Sudafrica 71
DK - Danimarca 67
TR - Turchia 63
IQ - Iraq 53
CO - Colombia 48
EC - Ecuador 47
CH - Svizzera 44
BE - Belgio 40
AU - Australia 39
CL - Cile 29
GR - Grecia 28
PT - Portogallo 25
VE - Venezuela 24
LT - Lituania 22
AE - Emirati Arabi Uniti 20
MA - Marocco 20
PY - Paraguay 20
UZ - Uzbekistan 19
PK - Pakistan 17
RO - Romania 17
SA - Arabia Saudita 16
KE - Kenya 15
PE - Perù 15
TW - Taiwan 15
IL - Israele 13
NZ - Nuova Zelanda 13
DZ - Algeria 12
MY - Malesia 12
IR - Iran 11
AZ - Azerbaigian 10
RS - Serbia 10
UY - Uruguay 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JM - Giamaica 9
KW - Kuwait 9
TN - Tunisia 9
BY - Bielorussia 8
EG - Egitto 8
JO - Giordania 8
KZ - Kazakistan 8
PH - Filippine 8
SC - Seychelles 8
ET - Etiopia 7
HU - Ungheria 7
NP - Nepal 7
TH - Thailandia 7
HN - Honduras 6
HR - Croazia 6
KG - Kirghizistan 6
NG - Nigeria 6
SN - Senegal 6
BG - Bulgaria 5
LK - Sri Lanka 5
NO - Norvegia 5
OM - Oman 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
AM - Armenia 4
BO - Bolivia 4
PA - Panama 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
CY - Cipro 3
EU - Europa 3
GE - Georgia 3
GY - Guiana 3
MN - Mongolia 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SI - Slovenia 3
BH - Bahrain 2
CD - Congo 2
Totale 33.780
Salva come PNG Salva come JPEG
Città #
Singapore 2.162
Hong Kong 1.911
Fairfield 1.558
Ann Arbor 1.273
Ashburn 1.259
Dublin 820
Chandler 741
Woodbridge 698
Wilmington 680
Houston 612
Seattle 593
Santa Clara 526
Dearborn 501
Cambridge 492
New York 491
Milan 442
Frankfurt am Main 435
Princeton 363
Ho Chi Minh City 339
Dallas 306
Hefei 292
Hanoi 261
Beijing 257
Los Angeles 249
Jakarta 233
Chicago 171
Nanjing 171
Lawrence 161
Jacksonville 153
Moscow 153
Altamura 152
São Paulo 126
Buffalo 121
Council Bluffs 119
Seoul 117
The Dalles 111
San Diego 104
Guangzhou 91
Nuremberg 89
Rome 89
Vienna 88
London 83
Shanghai 72
Tokyo 70
Toronto 63
Shenyang 62
Hebei 60
Jinan 58
Andover 57
Nanchang 55
Salt Lake City 55
Warsaw 55
Munich 53
Hangzhou 47
Helsinki 46
Phoenix 45
Changsha 43
Zhengzhou 40
Belo Horizonte 39
Da Nang 38
Madrid 36
Tianjin 36
Amsterdam 35
Atlanta 35
Dong Ket 35
Rio de Janeiro 35
Boardman 34
Columbus 33
Haiphong 33
Jiaxing 33
Denver 32
Lappeenranta 32
Montreal 32
Elk Grove Village 29
Norwalk 28
Quận Bình Thạnh 28
Brooklyn 27
Buenos Aires 26
Johannesburg 26
Ottawa 26
San Francisco 25
Stockholm 25
Tampa 25
Boston 24
Ningbo 23
Chennai 22
Mexico City 22
Wuhan 21
Biên Hòa 20
Porto Alegre 20
Baghdad 19
Bogotá 19
Brasília 19
Florence 19
Orem 19
Manchester 18
Poplar 18
Tashkent 18
Washington 18
Brussels 17
Totale 21.593
Salva come PNG Salva come JPEG
Nome #
Indications and utility of cardiac genetic testing in athletes 517
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 427
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 426
Genetic mechanisms of critical illness in COVID-19 421
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 416
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 415
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 401
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 366
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 365
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 310
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 304
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 293
Mapping the human genetic architecture of COVID-19 291
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 283
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 282
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 265
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 248
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 242
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 239
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 238
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 229
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 227
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 226
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 223
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 223
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 211
Infanticide vs. inherited cardiac arrhythmias. 197
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 181
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 175
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 173
The ICD for the long QT syndrome: which indications, complications, and results? 172
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 171
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 171
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 170
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 168
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 166
An explainable model of host genetic interactions linked to COVID-19 severity 166
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 166
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 165
Inherited Cardiac Arrhythmia Syndrome: Role of Potassium Channels 164
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 164
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 163
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 163
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 162
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 162
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 162
The genetics underlying acquired long QT syndrome: Impact for genetic screening 160
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 160
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents 160
Long and Short QT syndromes. 159
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 159
The Long QT Syndrome 159
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 158
Brugada and Long QT Syndrome are two different diseases: True or False? 158
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 158
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 157
Prevalence of the congenital long-qt syndrome 157
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 157
Neuroimmune crosstalk in the pathophysiology of hypertension. 157
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis] 156
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 156
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 156
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 156
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 155
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 154
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 154
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 153
Cardiac potassium channel dysfunction in sudden infant death syndrome 153
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 153
Whole-genome sequencing reveals host factors underlying critical COVID-19 151
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 151
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 151
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 151
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 150
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 150
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 150
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 150
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 149
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 149
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 149
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94]. (International Journal of Cardiology (2022) 357 (88–94), (S0167527322003850), (10.1016/j.ijcard.2022.03.028)) 148
A refined multiscale self-entropy approach for the assessment of cardiac control complexity: Application to long QT syndrome type 1 patients 147
Cardiac sodium channel dysfunction in sudden infant death syndrome 147
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 146
Long and Short QT Syndromes 145
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 144
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 144
QTc behavior during exercise and genetic testing for the long-QT syndrome 144
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 144
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis 142
Ion channel diseases in children: Manifestations and management 142
Genetic of adult and fetal forms of Long QT Syndrome. 142
Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions -A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology 141
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 139
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients 138
Founder populations with channelopathies and church records reveal all sorts of interesting secrets: Some are scientifically relevant 138
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study 137
Congenital long QT syndrome 137
Efficacy and safety of cardiac rehabilitation in patients with left ventricular thrombosis after acute myocardial infarction 136
Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia 136
Totale 19.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.815
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.888 0 0 0 0 0 264 543 300 182 231 181 187
2021/20221.909 153 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20258.756 466 1.208 617 332 622 347 456 358 1.061 1.102 673 1.514
2025/20268.321 1.772 1.303 1.285 1.696 2.059 206 0 0 0 0 0 0
Totale 35.047